SESN2 and colorectal carcinoma: The authors elucidated the molecular mechanism behind the potential contribution of SESN2 to counteract colorectal cancer (CRC) via the activation of AMPK, thereby down-regulating the mTORC1 pathway (Wei et al. 2017).